| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |